Search research articles
Contact Us
Filters
Showing results (21-30 of 77) with videos related to
Page
of 8
Sort By:
Talanta
|
October 11, 2015
Quantitative evaluation of berberine subcellular distribution and cellular accumulation in non-small cell lung cancer cells by UPLC-MS/MS
Zhong-Wen Yuan, Elaine Lai-Han Leung, Xing-Xing Fan, et al.
Pharmacological Research
|
April 5, 2024
Depletion of regulatory T cells enhancing the anti-tumor effect of in situ vaccination in solid tumors
Ya-Jia Xie, Sha Tian, Min Huang, et al.
Molecules (Basel, Switzerland)
|
March 26, 2014
Celastrol induces apoptosis in gefitinib-resistant non-small cell lung cancer cells via caspases-dependent pathways and Hsp90 client protein degradation
Xing-Xing Fan, Na Li, Jian-Lin Wu, et al.
Chinese Medicine
|
July 16, 2020
Current strategies against COVID-19
Shahid Hussain, Ya-Jia Xie, Dan Li, et al.
BMC Medicine
|
December 9, 2022
Tumor PKCδ instigates immune exclusion in EGFR-mutated non-small cell lung cancer
Yi-Han Zuo, Wei-Na Gao, Ya-Jia Xie, et al.
Pharmacological Research
|
June 21, 2019
Long-term efficacy of Chinese medicine Bushen Capsule on cognition and brain activity in patients with amnestic mild cognitive impairment
Junying Zhang, Caishui Yang, Dongfeng Wei, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer
|
April 18, 2026
Metabolites in the tumor microenvironment: Key drivers of immune cell fate and function as therapeutic targets in cancer
Xiao-Ping Zhao, Chu-Tian Mai, Yi-Lin Zhao, et al.
Pharmacological Research
|
October 17, 2022
Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer
Ying Xie, Sen-Ling Feng, Fang He, et al.
Heliyon
|
June 12, 2023
DMU-212 against EGFR-mutant non-small cell lung cancer via AMPK/PI3K/Erk signaling pathway
Xiao-Ping Zhao, Xiao-Li Zheng, Min Huang, et al.
Pharmacological Research
|
November 20, 2016
Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway
Xia Li, Xing-Xing Fan, Ze-Bo Jiang, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 77) with videos related to
Sort By:
Page
of 8
Talanta
|
October 11, 2015
Quantitative evaluation of berberine subcellular distribution and cellular accumulation in non-small cell lung cancer cells by UPLC-MS/MS
Zhong-Wen Yuan, Elaine Lai-Han Leung, Xing-Xing Fan, et al.
Pharmacological Research
|
April 5, 2024
Depletion of regulatory T cells enhancing the anti-tumor effect of in situ vaccination in solid tumors
Ya-Jia Xie, Sha Tian, Min Huang, et al.
Molecules (Basel, Switzerland)
|
March 26, 2014
Celastrol induces apoptosis in gefitinib-resistant non-small cell lung cancer cells via caspases-dependent pathways and Hsp90 client protein degradation
Xing-Xing Fan, Na Li, Jian-Lin Wu, et al.
Chinese Medicine
|
July 16, 2020
Current strategies against COVID-19
Shahid Hussain, Ya-Jia Xie, Dan Li, et al.
BMC Medicine
|
December 9, 2022
Tumor PKCδ instigates immune exclusion in EGFR-mutated non-small cell lung cancer
Yi-Han Zuo, Wei-Na Gao, Ya-Jia Xie, et al.
Pharmacological Research
|
June 21, 2019
Long-term efficacy of Chinese medicine Bushen Capsule on cognition and brain activity in patients with amnestic mild cognitive impairment
Junying Zhang, Caishui Yang, Dongfeng Wei, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer
|
April 18, 2026
Metabolites in the tumor microenvironment: Key drivers of immune cell fate and function as therapeutic targets in cancer
Xiao-Ping Zhao, Chu-Tian Mai, Yi-Lin Zhao, et al.
Pharmacological Research
|
October 17, 2022
Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer
Ying Xie, Sen-Ling Feng, Fang He, et al.
Heliyon
|
June 12, 2023
DMU-212 against EGFR-mutant non-small cell lung cancer via AMPK/PI3K/Erk signaling pathway
Xiao-Ping Zhao, Xiao-Li Zheng, Min Huang, et al.
Pharmacological Research
|
November 20, 2016
Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway
Xia Li, Xing-Xing Fan, Ze-Bo Jiang, et al.
Page
of 8